الفهرس 
Modulation potential of HMGBX1/TLR4 signaling pathway in pentylenetetrazol-induced kindling epilepsy in rats by pentoxifylline
Abstract EnglishOnly 14 pages are availabe for public view
 |  | from | 167 |  |  |
| | | from | 167 | | |
Abstract
Epilepsy is a chronic widely prevalent neurologic disease.It affects brain functions with broad spectrum of deleterious consequences. High-mobility group box1 (HMGB1) is a nuclear non-histone protein targets vital cell receptor of toll like receptor 4 (TLR4) and advanced glycation end products (RAGE). HMGB1 mediated TLR4/RAGE cascade has been scored as a main culprit in neuro-inflammatory signaling that critically evokes development of impaired epilepsyandcognition. The current study aimed to investigate the neuroprotective effect of pentoxifylline (PTX) on pentylenetetrazol (PTZ)-Kindling rats by its anti-inflammatory/antioxidant capacity besides its impact on memory and cognition were investigated, too. PTZ was intraperitoneally injected 35 mg/kg, every (48) hours, for 14 doses, to evoke kindling model. Phenytoin (30 mg/kg, i.p.) and PTX (60 mg/kg, i.p.) or their combination were given once daily for 27 days. PTX treatment showed a statistically significant effect on behavioral, histopathological and neurochemical analysis. PTX protected the PTZ kindling rats from epileptic seizures and improved memory and cognitive impairment in Morris water maze (MWM) test. Furthermore, PTX reversed PTZ hippocampal neuronal loss by decreasing protein expression of amyloid-Ý peptide protein (AÝ), Tau and Ý site-amyloid precursor protein-cleavage enzyme 1 (BACE1), associated with a marked reduction in expression of inflammatory mediators such as HMGB1, TLR4, RAGE proteins, IL-1Ý, and nuclear factor kappa-Ý (NF-mB). Furthermore, PTX inhibited hippocampal caspase 1 protein and led to inhibition of neuronal cell death. Also, PTX lowered total reactive oxygen species (TROS) along with upregulated erythroid 2-related factor 2 (Nrf2) content, so it decreasedthe level of oxidative stress